Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial

Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial - CATCH trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035584

Enrollment

Registered

2019-01-23

Start date

2018-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra cerebral hemorrhage

Interventions

We assigned the patients to one group given 750 mg/day of tranexamic acid for 14 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who undergo nonsurgical treatment of spontaneous intracerebral hemorrhage

Exclusion criteria

Exclusion criteria: GCS <9; treatment window >8h; intracerebral hemorrhage secondary to anticoagulation, thrombolysis, trauma, or a known underlying structural abnormality; patients for whom tranexamic acid was thought to be contraindicaterd; prestroke mRS >4; patients who receive surgical treatment; multiple intracerebral hemorrhage

Design outcomes

Primary

Measure	Time frame
Glasgow Coma Scale at 1 week and at discharge	—

Countries

Japan

Contacts

Public ContactYuri Iwasaki

Hitoyoshi Medical Center Clinical research center

iwasaki-yuri@hitoyoshi.jcho.go.jp0966-22-2191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026